The MaxRP® policy is our maximum recommended price to the consumer
A QR code on the Civica insulin glargine-yfgn product label enables healthcare providers, caregivers, patients and others to compare prices and confirm they are being charged no more than the MaxRP. If you paid more than the MaxRP, please contact us >
How to get Civica insulin glargine-yfgn
If you have health insurance, check your plan’s formulary to ensure Civica insulin glargine-yfgn is listed. If so, just ask your pharmacy to order it when you take in your new or refill prescription.
Cash-paying patients can buy Civica insulin glargine-yfgn at the same low price. Ask your pharmacy to order it when you take in your new or refill prescription.
For Californians: Civica insulin glargine-yfgn will be available under the CalRx® brand in California pharmacies.
Civica insulin glargine-yfgn is interchangeable with Lantus.
How to inject Civica insulin glargine-yfgn
Frequently asked questions
Do I need a prescription to access Civica insulin glargine-yfgn?
Yes, a prescription is necessary to access Civica insulin glargine-yfgn. If you have an existing current prescription for insulin glargine, including brand names like Lantus, you do not need a new prescription to access Civica insulin glargine-yfgn because the products are interchangeable. Ask your healthcare provider if you need a new prescription and talk with your pharmacist about filling your prescription with Civica insulin glargine-yfgn.
How much does Civica insulin glargine-yfgn cost?
Civica recommends that pharmacies and health plans set a maximum recommended price for consumers of no more than $55 per box of five prefilled pens. Your cost may be even lower than $55, depending on your insurance plan.
This single low, stable, transparent price, without hidden rebates and unfair markups, is the lowest list price in the current long-acting insulin market. This contrasts with other manufacturers’ copay assistance programs that require registration and can change anytime.
Is Civica insulin glargine-yfgn covered by my health insurance?
Civica insulin glargine-yfgn is sold at a single low cost regardless of health insurance coverage. You do not need health insurance to purchase it. However, your out-of-pocket costs could be even lower, as low as zero dollars, depending on your health insurance program. Talk to your health insurance company about your prescription drug benefits.
Are Civica insulin glargine-yfgn and CalRx insulin glargine-yfgn the same product?
Yes, they are the same product with different branding. The CalRx-branded product is available to Californians under a California state initiative to make essential drugs more affordable. The Civica-branded product is available nationwide.
Important Safety Information about insulin glargine-yfgn
Do not dilute or mix insulin glargine-yfgn with any other insulin or solution. If mixed or diluted, the solution may become cloudy, and the onset of action/time to peak effect may be altered in an unpredictable manner. Do not administer insulin glargine-yfgn via an insulin pump or intravenously because hypoglycemia can occur.
For full prescribing information and patient information, including warnings and precautions, potential adverse reactions and drug interactions, please refer to the Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit Med Watch or call 1-800-FDA-1088.
IMPORTANT SAFETY INFORMATION
Do not share your pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Do not use Insulin Glargine-yfgn if you are having an episode of low blood sugar or if you are allergic to insulin glargine products or any of the ingredients in Insulin Glargine-yfgn.
Do NOT reuse needles.
Before using Insulin Glargine-yfgn, tell your healthcare provider about all your medical conditions including if you:
• have liver or kidney problems.
• take other medicines, especially ones called TZDs (thiazolidinediones).
• have heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with Insulin Glargine-yfgn.
• are pregnant, planning to become pregnant, or are breastfeeding. It is not known if Insulin Glargine-yfgn may harm your unborn baby or breastfeeding baby.
Tell your healthcare provider about all the medicines you take including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Before you start using Insulin Glargine-yfgn, talk to your healthcare provider about low blood sugar and how to manage it.
Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged. While injecting Insulin Glargine-yfgn, do not press hard, slowly push the injection button to inject the dose. Tell your doctor if you have any new or worsening symptoms of heart failure, including shortness of breath, swelling of your ankles or feet, sudden weight gain.
Insulin Glargine-yfgn should be taken once a day at the same time every day. Test your blood sugar levels while using insulin, such as Insulin Glargine-yfgn. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.
Do NOT dilute or mix Insulin Glargine-yfgn with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Insulin Glargine-yfgn must only be used if the solution is clear and colorless with no particles visible. Always make sure you have the correct insulin before each injection.
While using Insulin Glargine-yfgn, do not drive or operate heavy machinery until you know how Insulin Glargine-yfgn affects you. You should not drink alcohol or use other medicines that contain alcohol.
The most common side effect of insulin, including Insulin Glargine-yfgn, is low blood sugar (hypoglycemia), which may be serious and life threatening.
Signs and symptoms that may indicate low blood sugar include dizziness or light-headedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability or mood change, hunger.
Insulin Glargine-yfgn may cause serious side effects that can lead to death, such as severe allergic reactions. Get medical help right away if you have: a rash over your whole body, trouble breathing, shortness of breath, a fast heartbeat, sweating, swelling of your face, tongue, or throat, extreme drowsiness, dizziness, or confusion.
Other possible side effects may include swelling, weight gain, low potassium levels, injection site reactions, allergic reactions and skin thickening or pits at the injection site.
Important Safety Information for Insulin Glargine-yfgn injection pen
Insulin Glargine-yfgn pen is a disposable single-patient-use prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.
These are not all the possible side effects of Insulin Glargine-yfgn. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
This summary does not include all the information about Insulin Glargine-yfgn and is not meant to take the place of a discussion with your healthcare provider about your treatment.
What is Insulin Glargine-yfgn injection 100 Units/mL?
Insulin Glargine-yfgn is a prescription long-acting man-made insulin used to control high blood sugar in adults and children with diabetes.
• Insulin Glargine-yfgn is not for use to treat diabetic ketoacidosis.